Solara Active Pharma Sciences Limited SOLARA.BO Stock
Solara Active Pharma Sciences Limited Price Chart
Solara Active Pharma Sciences Limited SOLARA.BO Financial and Trading Overview
Solara Active Pharma Sciences Limited stock price | 409.25 INR |
Previous Close | 376.15 INR |
Open | 379.25 INR |
Bid | 380.9 INR x 0 |
Ask | 381.15 INR x 0 |
Day's Range | 377.75 - 389.65 INR |
52 Week Range | 323.65 - 494.9 INR |
Volume | 26.7K INR |
Avg. Volume | 50.24K INR |
Market Cap | 13.71B INR |
Beta (5Y Monthly) | 0.55264 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -85.62 INR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | August 18, 2021 |
1y Target Est | N/A |
SOLARA.BO Valuation Measures
Enterprise Value | 23.57B INR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.94939023 |
Price/Book (mrq) | 0.91136885 |
Enterprise Value/Revenue | 1.632 |
Enterprise Value/EBITDA | 17.6 |
Trading Information
Solara Active Pharma Sciences Limited Stock Price History
Beta (5Y Monthly) | 0.55264 |
52-Week Change | 7.44% |
S&P500 52-Week Change | 20.43% |
52 Week High | 494.9 INR |
52 Week Low | 323.65 INR |
50-Day Moving Average | 363.06 INR |
200-Day Moving Average | 405.42 INR |
SOLARA.BO Share Statistics
Avg. Volume (3 month) | 50.24K INR |
Avg. Daily Volume (10-Days) | 55.14K INR |
Shares Outstanding | 36M |
Float | 14.56M |
Short Ratio | N/A |
% Held by Insiders | 60.42% |
% Held by Institutions | 19.46% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | -1.53% |
Operating Margin (ttm) | 1.57% |
Gross Margin | 45.36% |
EBITDA Margin | 9.27% |
Management Effectiveness
Return on Assets (ttm) | 0.48% |
Return on Equity (ttm) | -1.46% |
Income Statement
Revenue (ttm) | 14.44B INR |
Revenue Per Share (ttm) | 401.17 INR |
Quarterly Revenue Growth (yoy) | 5.50% |
Gross Profit (ttm) | N/A |
EBITDA | 1.34B INR |
Net Income Avi to Common (ttm) | -221700000 INR |
Diluted EPS (ttm) | -6.55 |
Quarterly Earnings Growth (yoy) | 100.49% |
Balance Sheet
Total Cash (mrq) | 88.9M INR |
Total Cash Per Share (mrq) | 2.48 INR |
Total Debt (mrq) | 10.13B INR |
Total Debt/Equity (mrq) | 67.41 INR |
Current Ratio (mrq) | 1.078 |
Book Value Per Share (mrq) | 417.833 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.56B INR |
Levered Free Cash Flow (ttm) | -207400000 INR |
Profile of Solara Active Pharma Sciences Limited
Country | India |
State | N/A |
City | Chennai |
Address | Admin Block 27 |
ZIP | 600127 |
Phone | 91 44 4344 6700 |
Website | https://www.solara.co.in |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.
Q&A For Solara Active Pharma Sciences Limited Stock
What is a current SOLARA.BO stock price?
Solara Active Pharma Sciences Limited SOLARA.BO stock price today per share is 409.25 INR.
How to purchase Solara Active Pharma Sciences Limited stock?
You can buy SOLARA.BO shares on the BSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Solara Active Pharma Sciences Limited?
The stock symbol or ticker of Solara Active Pharma Sciences Limited is SOLARA.BO.
Which industry does the Solara Active Pharma Sciences Limited company belong to?
The Solara Active Pharma Sciences Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Solara Active Pharma Sciences Limited have in circulation?
The max supply of Solara Active Pharma Sciences Limited shares is 36M.
What is Solara Active Pharma Sciences Limited Price to Earnings Ratio (PE Ratio)?
Solara Active Pharma Sciences Limited PE Ratio is now.
What was Solara Active Pharma Sciences Limited earnings per share over the trailing 12 months (TTM)?
Solara Active Pharma Sciences Limited EPS is -85.62 INR over the trailing 12 months.
Which sector does the Solara Active Pharma Sciences Limited company belong to?
The Solara Active Pharma Sciences Limited sector is Healthcare.